Wird geladen...
Brivaracetam in the treatment of epilepsy: a review of clinical trial data
Brivaracetam (BRV), an analog of levetiracetam (LEV), was discovered during a target-based rational drug discovery program that aimed to identify potent synaptic vesicle protein 2A (SV2A) ligands. Among the 12,000 compounds screened in vitro, BRV was found to have 15–30 times greater affinity for SV...
Gespeichert in:
| Veröffentlicht in: | Neuropsychiatr Dis Treat |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Dove
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6750854/ https://ncbi.nlm.nih.gov/pubmed/31571877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S143548 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|